electronic health records Archives
Functional seizures associated with stroke, psychiatric disorders in electronic health records study
Jan. 7, 2021—In a large-scale study of electronic health records, Vanderbilt University Medical Center investigators have determined the prevalence of functional seizures and characterized comorbidities associated with them.
COVID-associated delays for elective services studied
Dec. 17, 2020—This spring in the U.S., there were widespread delays in elective health care procedures and screenings. Hospitals, in observance of federal guidelines, were, for a time, conserving beds and protective equipment in preparation for a surge in COVID-19 admissions. And, perhaps on a more prolonged basis, patients in many areas of the country stayed away due to anxiety over catching COVID-19 from other patients or their health care team.
Team tracks sources of false positives in urine drug screens
Dec. 3, 2020—False positives on urine drug screens are common and are frequently due to cross-reactivity of these tests to medications. Last year, Vanderbilt University Medical Center researchers Jacob Hughey, PhD, assistant professor of Biomedical Informatics, and Jennifer Colby, PhD, at that time assistant professor of Pathology, Microbiology and Immunology, devised, tested and published a method to systematically identify medications that interfere with screenings for drugs of abuse.
Study tracks physician use of electronic health records
Nov. 4, 2020—According to a new large-scale descriptive study in the journal Pediatrics, for each outpatient encounter, pediatricians on average spend 16 minutes using the electronic health record (EHR).
New tool rapidly identifies health records for studies
Oct. 29, 2020—Electronic health records (EHR) are increasingly a resource for biomedical discovery, and automated searches for records that reflect a phenotype of interest, typically a disease, are a common starting point.
Initiative seeks to extract cancer phenotypes from electronic health records
Oct. 15, 2020—The National Cancer Institute (NCI) has funded the development of interactive visual tools that will allow researchers to extract cancer phenotypes from electronic medical records.
Computer-based study reveals impact of race on health
Oct. 8, 2020—A computer-based method developed at Vanderbilt University Medical Center that scans electronic medical records (EMRs) for genetic contributors to disease has been used for the first time to reveal the impact of race on health.
VUMC teams working to adopt new federal EHR rules
Oct. 8, 2020—Vanderbilt University Medical Center is working toward a Nov. 1 date to comply with key parts of new federal rules issued by the Centers for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC), as part of the 21st Century Cures Act.
Award supports integration of genomic data, electronic health records
Sep. 10, 2020—Eric Gamazon, PhD, assistant professor of Medicine, has been awarded a $1.5 million grant from the National Human Genome Research Institute, part of the National Institutes of Health (NIH), to develop novel computational tools that integrate functional genomic data and electronic health records.
Clickbusters program takes on EHR alert fatigue
Jul. 16, 2020—On April 1, the Vanderbilt Clinical Informatics Center (VCLIC), in coordination with Health IT, launched a grassroots program called Clickbusters to stem alert fatigue at Vanderbilt University Medical Center.
Facial recognition solves patient identification: study
Jul. 1, 2020—Patient misidentification is an all too common cause of medical error. In low- and middle-income countries, free, open-source facial recognition software could provide an economical solution for verifying patient identity across health care settings, according to a study by Martin Were, MD, MS, and colleagues, appearing in the International Journal of Medical Informatics.
Target trials support drug safety in pregnant patients
May. 27, 2020—Out of concern for fetal safety, pregnant people have typically been excluded from drug trials. And when human health is on the line, drug studies assessing fetal safety in animal models may be viewed as far from definitive.
